Ozempic was first approved to treat diabetes in Canada seven years ago. Now the largest study of its kind suggests it and other medications like it have a host of other potential health benefits ...

A new study shows that GLP-1 drugs offer health benefits such as reducing risks for heart disease but also carry potential risks like gastrointestinal issues.

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Sure, who wouldn’t want to lose a few pounds? But what’s really driving Hollywood’s latest trend is the drug’s seemingly miraculous side benefits ...

But some of the results were unexpected, including how these drugs can help with things ... increased risk of arthritis. via REUTERS Semaglutide — the active ingredient in Ozempic and Wegovy ...

However, GLP-1 medications aren't without side effects and its use is linked to acid reflux, headaches, pancreatitis, and an increased risk of arthritis ... Ozempic: Does the drug really help ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected but contain surprises, too.

Few drugs have captured public attention like Ozempic; many of us have even taken ... which release GLP-1 when you eat to help control your blood sugar. The relationship with glucose metabolism ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing weight.